Kinaxo Buys LC-MS System to Meet Pharma Demand, Enable Phosphoproteome Analysis | GenomeWeb
Proteomics start-up Kinaxo Biotechnologies has purchased its first liquid chromatography-mass spectrometry platform, allowing it to bring its protein-analysis services in house and expand its technologies and capabilities.
 
The purchase was made with Kinaxo’s second-ever round of venture capital funding and comes as it sees strong demand for its services, even as many protein-service firms have either dried up or are hanging on by their finger tips in the challenging environment.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.